Intended for healthcare professionals

Letter

Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: What does evidence from randomised trials show about celecoxib?

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7530.1474-c (Published 15 December 2005) Cite this as: BMJ 2005;331:1474

Article usage

Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.

Usage statistics: January 2018 to April 2024

Rendering graph...
AbstractFullPdf
Jan 2018500
Feb 2018900
Mar 2018600
Apr 2018610
May 2018600
Jun 2018400
Jul 2018210
Aug 2018500
Sep 2018200
Oct 2018400
Nov 2018300
Dec 2018500
Jan 20198330
Feb 20192020
Mar 20192310
Apr 2019900
May 2019700
Jun 2019500
Jul 2019500
Aug 2019500
Oct 2019100
Nov 2019400
Dec 2019300
Jan 2020400
Feb 2020700
Mar 2020100
May 2020200
Jun 2020100
Jul 20201810
Aug 2020030
Sep 2020500
Oct 20203300
Nov 20203510
Dec 20201110
Jan 2021600
Feb 2021300
Mar 2021400
Apr 20211100
May 2021700
Jun 2021200
Jul 2021310
Aug 20211220
Sep 2021300
Oct 2021800
Nov 2021100
Dec 2021500
Jan 2022200
Feb 2022400
Mar 2022300
Apr 2022300
May 2022900
Jun 20221010
Jul 2022910
Aug 2022210
Oct 2022100
Nov 2022120
Dec 2022700
Jan 2023300
Feb 2023620
Mar 2023010
Apr 2023700
May 20231000
Jun 2023410
Aug 2023200
Sep 2023800
Oct 2023510
Nov 2023400
Dec 2023300
Jan 20243800
Feb 20241400
Mar 2024200
Apr 2024200
Total563270